Oncologix Tech Revenue Growth Rates (OCLG), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Oncologix Tech Inc.  (OCLG)
 

OCLG's Revenue Growth by Quarter and Year

Oncologix Tech's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OCLG Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
4th Quarter August -
3rd Quarter May 1.24
2nd Quarter February 1.23
1st Quarter November 1.16
FY 3.63





OCLG Revenue third quarter 2015 Y/Y Growth Comment
Oncologix Tech Inc. reported Revenue improvement of 24.81% year on year in the third quarter 2015, to $ 1.24 millions, this is lower than Oncologix Tech Inc.'s recent average Revenue surge of 754.85%.
This represents worst decline in recent Company history.

Looking into third quarter 2015 results within Medical Equipment & Supplies industry 38 other companies have achieved higher Revenue growth. While Oncologix Tech Inc.' s Revenue rise of 24.81% ranks overall at the positon no. 877 in the third quarter 2015.


OCLG Revenue ( Y/Y Growth %) 2015
 2014 2013 2012
4th Quarter August - 345.45 % - -
3rd Quarter May 24.81 % 3200 % - -
2nd Quarter February 25.51 % - - -
1st Quarter November 61.11 % - - -
FY   - 1368 % - -

Financial Statements
Oncologix Tech's third quarter 2015 Revenue $ 1.24 millions OCLG's Income Statement
Oncologix Tech's third quarter 2014 Revenue $ 0.99 millions Quarterly OCLG's Income Statement


OCLG Revenue (Quarter on Quarter Growth %)

 2015
 2014 2013 2012
4th Quarter August - -1.01 % 633.33 % -
3rd Quarter May 0.46 % 1.02 % - -
2nd Quarter February 6.03 % 36.11 % - -
1st Quarter November 18.37 % 227.27 % - -
FY (Year on Year)   - 1368 % - -


Back to OCLG Growth rate Comparisons >> Back to OCLG Growth rate Comparisons >>


Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #189
Overall #877

Revenue Y/Y Growth Statistics
High Average Low
3308.46 % 754.85 % 24.81 %
(May 31 2014)   (Feb 28 2015)
Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #189
Overall #877
Revenue Y/Y Growth Statistics
High Average Low
3308.46 % 754.85 % 24.81 %
(May 31 2014)   (Feb 28 2015)

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

Oncologix Tech's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
642.29 % 117.4 % -0.78 %
(Aug 31 2013)  


OCLG's III. Quarter Q/Q Revenue Comment
Oncologix Tech Inc. achieved in the III. Quarter 2015 below company average Revenue growth of 0.46% quarter on quarter, to $ 1.24 millions.

Within Medical Equipment & Supplies industry 105 other companies have achieved higher Revenue quarter on quarter growth. While Oncologix Tech's Revenue growth quarter on quarter, overall rank is 2642.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #106
Healthcare Sector #334
Overall #2642
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #106
Healthcare Sector #334
Overall #2642
Revenue Q/Q Growth Statistics
High Average Low
642.29 % 117.4 % -0.78 %
(Aug 31 2013)  


OCLG's III. Quarter Q/Q Revenue Comment
Oncologix Tech Inc. achieved in the III. Quarter 2015 below company average Revenue growth of 0.46% quarter on quarter, to $ 1.24 millions.

Within Medical Equipment & Supplies industry 105 other companies have achieved higher Revenue quarter on quarter growth. While Oncologix Tech's Revenue growth quarter on quarter, overall rank is 2642.


Oncologix Tech's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2015)		 12 Months Ending
(Feb 28 2015)		 12 Months Ending
(Nov 30 2014)		 12 Months Ending
(Aug 31 2014)		 12 Months Ending
(May 31 2014)
Cumulative Revenue 12 Months Ending $ 4.61 $ 4.36 $ 4.11 $ 3.68 $ 2.91
Y / Y Revenue Growth (TTM) 58.18 % 123.23 % - - -
Year on Year Revenue Growth Overall Ranking # 314 # 369 # 370 # 0 # 0
Seqeuential Revenue Change (TTM) 5.67 % 5.93 % 11.89 % 26.29 % 49.13 %
Seq. Revenue Growth (TTM) Overall Ranking # 373 # 690 # 0 # 0 # 366


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the May 31 2015 period, Oncologix Tech's cumulative twelve months Revenue were $ 5 millions, company would post below average annual Revenue growth of 49.13% year on year, if the fiscal year would end at May 31 2015.
A slow-down in the Oncologix Tech's Revenue growth from the 1.23% growth in Feb 28 2015.

In the Healthcare sector 76 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 314, from total ranking in previous quarter at 369.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 14
Healthcare Sector # 77
Overall # 314

Revenue TTM Y/Y Growth Statistics
High Average Low
123.23 %
 90.7 %
58.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 81
S&P 500 # 373
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the May 31 2015 period, Oncologix Tech's cumulative twelve months Revenue were $ 5 millions, company would post below average annual Revenue growth of 58.18% year on year, if the fiscal year would end at May 31 2015.
A slow-down in the Oncologix Tech's Revenue growth from the 1.23% growth in Feb 28 2015.

In the Healthcare sector 76 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 314, from total ranking in previous quarter at 369.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 14
Healthcare Sector # 77
Overall # 314

Revenue TTM Y/Y Growth Statistics
High Average Low
123.23 %
90.7 %
58.18 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 81
S&P 500 # 373




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OCLG's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending May 31 2015 within Healthcare SectorY/Y Change %Revenue for the quarter ending May 31 2015
Cerevel Therapeutics Holdings Inc 39.58%$ 39.578 millions
Oncologix Tech Inc.25.02%$ 25.018 millions
Neogen Corporation16.87%$ 16.873 millions


About Oncologix Tech Revenue Growth Rates (OCLG), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.